Literature DB >> 9666534

Long-term outcomes after deep venous thrombosis of the lower extremities.

P Prandoni1, A W Lensing, M R Prins.   

Abstract

Few natural history studies are available which describe long-term outcomes after venous thromboembolism. However, symptomatic deep-vein thrombosis (DVT) of the lower extremities carries a high risk for recurrent venous thromboembolism that persists for many years. This risk is higher among patients with permanent risk factors including inherited abnormalities of hemostasis than among patients who have suffered trauma or who are postoperative. The development of recurrent ipsilateral DVT carries a high risk for severe post-thrombotic syndrome, an otherwise rare problem in patients with a first episode of DVT adequately treated with anticoagulant drugs and wearing vascular compression stockings. Long-term survival following DVT is generally good in the absence of malignancy. Carefully designed randomized trials are needed to determine whether chronic anticoagulation can reduce further the risks of recurrent DVT and symptoms of post-thrombotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666534     DOI: 10.1177/1358836X9800300112

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  11 in total

Review 1.  Diagnosis and treatment of deep-vein thrombosis.

Authors:  Dimitrios Scarvelis; Philip S Wells
Journal:  CMAJ       Date:  2006-10-24       Impact factor: 8.262

Review 2.  Hepatic findings in long-term clinical trials of ximelagatran.

Authors:  William M Lee; Dominique Larrey; Rolf Olsson; James H Lewis; Marianne Keisu; Laurent Auclert; Sunita Sheth
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran.

Authors:  Henry Eriksson
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

Authors:  Eduardo Ramacciotti; Daniel D Myers; Shirley K Wrobleski; K Barry Deatrick; Frank J Londy; John E Rectenwald; Peter K Henke; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-04       Impact factor: 3.944

Review 5.  Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.

Authors:  Sean D Sullivan; Susan R Kahn; Bruce L Davidson; Lars Borris; Patrick Bossuyt; Gary Raskob
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  Diagnosis and treatment of deep-vein thrombosis and approach to venous thromboembolism in obstetrics and gynecology.

Authors:  K Mehmet Burgazlı; Mehmet Bilgin; Ethem Kavukçu; M Metin Altay; H Turhan Ozkan; Uğur Coşkun; Hakan Akdere; A Kubilay Ertan
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-01

7.  The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial.

Authors:  Daniel Horner; Kerstin Hogg; Richard Body; Michael J Nash; Kevin Mackway-Jones
Journal:  Trials       Date:  2012-04-02       Impact factor: 2.279

8.  Which orally administered antithrombotic agent is most effective for preventing venous thromboembolism after total knee arthroplasty? A propensity score-matching analysis.

Authors:  Seonpyo Jang; Woo Cheol Shin; Min Ku Song; Hyuk-Soo Han; Myung Chul Lee; Du Hyun Ro
Journal:  Knee Surg Relat Res       Date:  2021-03-20

9.  Haemodynamic performance of neuromuscular electrical stimulation (NMES) during recovery from total hip arthroplasty.

Authors:  Barry J Broderick; Oisin Breathnach; Finbarr Condon; Eric Masterson; Gearóid Ólaighin
Journal:  J Orthop Surg Res       Date:  2013-03-05       Impact factor: 2.359

10.  Association between hypertension and deep vein thrombosis after orthopedic surgery: a meta-analysis.

Authors:  Lei Huang; Jie Li; Yong Jiang
Journal:  Eur J Med Res       Date:  2016-03-22       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.